Evidence map›Paper›PMID 36875306›Full record

ArticleCancer diagnosis & prognosis

Long-term Prognostic Impact of Metachronous Rectal Cancer in Patients With Familial Adenomatous Polyposis: A Single-center Retrospective Study.

Kyota Tatsuta, Mayu Sakata, Moriya Iwaizumi, Kosuke Sugiyama, Tadahiro Kojima, Toshiya Akai, Katsunori Suzuki, Yoshifumi Morita, Hirotoshi Kikuchi, Yoshihiro Hiramatsu and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kyota TatsutaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mayu SakataDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Moriya IwaizumiDepartment of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kosuke SugiyamaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Tadahiro KojimaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Toshiya AkaiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Katsunori SuzukiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yoshifumi MoritaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hirotoshi KikuchiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yoshihiro HiramatsuDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kiyotaka KurachiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hiroya TakeuchiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hamamatsu University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the risk factors and long-term prognosis of metachronous rectal cancer in the remnant rectum of patients with familial adenomatous polyposis (FAP). PATIENTS AND

methodsSixty-five patients (49 families) who underwent prophylactic surgery, including bowel resection, for FAP between January 1976 and August 2022 at Hamamatsu University Hospital were included and divided into two groups based on the presence of metachronous rectal cancer. Risk factors for metachronous rectal cancer development were analysed in cases treated with total colectomy with ileorectal anastomosis (IRA) and stapled total proctocolectomy with ileal pouch anal anastomosis (IPAA) (IRA, n=22; stapled IPAA n=20; total, n=42).

resultsThe median surveillance period was 169 months. Twelve patients developed metachronous rectal cancer (IRA, n=5; stapled IPAA, n=7), of which six with advanced cancer died. Patients who temporarily dropped out of surveillance were significantly more likely to have metachronous rectal cancer (metachronous vs. non-metachronous rectal cancer: 33.3% vs. 1.9%, p<0.01). The mean duration of surveillance suspension was 87.8 months. Cox regression analysis revealed that temporary surveillance drop-out independently affected the risk (p=0.04). The overall survival associated with metachronous rectal cancer was 83.3% at 1 year and 41.7% at 5 years. Overall survival was significantly worse in advanced cancer than in early cancer cases (p<0.01).

conclusionTemporary drop-out from surveillance was a risk factor for metachronous rectal cancer development, and advanced cancer had a poor prognosis. Continuous surveillance of patients with FAP, without temporary drop-out, is strongly recommended.

Indexed as

Familial adenomatous polyposisileal pouch anal anastomosisileorectal anastomosismetachronous rectal cancer

Identifiers

PMID36875306
PMCPMC9949552
OpenAlexW4323295490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.